If the phase 2 trials are as expected this stock should leave $1 inits wake-it really could be anything!!!Todays FIN REVIEW "Avexa could be on a pharmaceutical goldmine"-go the VEX
TIG Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint